Compugen Stock Market Value
CGEN Stock | USD 1.41 0.04 2.76% |
Symbol | Compugen |
Compugen Price To Book Ratio
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Compugen. If investors know Compugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Compugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.03 | Revenue Per Share 0.48 | Quarterly Revenue Growth 3.461 | Return On Assets (0.03) | Return On Equity (0.16) |
The market value of Compugen is measured differently than its book value, which is the value of Compugen that is recorded on the company's balance sheet. Investors also form their own opinion of Compugen's value that differs from its market value or its book value, called intrinsic value, which is Compugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Compugen's market value can be influenced by many factors that don't directly affect Compugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Compugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Compugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Compugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Compugen 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Compugen's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Compugen.
08/02/2023 |
| 11/24/2024 |
If you would invest 0.00 in Compugen on August 2, 2023 and sell it all today you would earn a total of 0.00 from holding Compugen or generate 0.0% return on investment in Compugen over 480 days. Compugen is related to or competes with Biomx, Pluri, BioLineRx, Iteos Therapeutics, Annexon, Allogene Therapeutics, and Beam Therapeutics. Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes ... More
Compugen Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Compugen's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Compugen upside and downside potential and time the market with a certain degree of confidence.
Information Ratio | (0.18) | |||
Maximum Drawdown | 16.24 | |||
Value At Risk | (7.61) | |||
Potential Upside | 5.23 |
Compugen Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Compugen's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Compugen's standard deviation. In reality, there are many statistical measures that can use Compugen historical prices to predict the future Compugen's volatility.Risk Adjusted Performance | (0.10) | |||
Jensen Alpha | (0.78) | |||
Total Risk Alpha | (1.05) | |||
Treynor Ratio | (0.23) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Compugen's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Compugen Backtested Returns
Compugen secures Sharpe Ratio (or Efficiency) of -0.15, which signifies that the company had a -0.15% return per unit of risk over the last 3 months. Compugen exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Compugen's Standard Deviation of 3.47, risk adjusted performance of (0.10), and Mean Deviation of 2.58 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 2.23, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Compugen will likely underperform. At this point, Compugen has a negative expected return of -0.51%. Please make sure to confirm Compugen's kurtosis, and the relationship between the maximum drawdown and day median price , to decide if Compugen performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.44 |
Modest reverse predictability
Compugen has modest reverse predictability. Overlapping area represents the amount of predictability between Compugen time series from 2nd of August 2023 to 29th of March 2024 and 29th of March 2024 to 24th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Compugen price movement. The serial correlation of -0.44 indicates that just about 44.0% of current Compugen price fluctuation can be explain by its past prices.
Correlation Coefficient | -0.44 | |
Spearman Rank Test | -0.46 | |
Residual Average | 0.0 | |
Price Variance | 0.05 |
Compugen lagged returns against current returns
Autocorrelation, which is Compugen stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Compugen's stock expected returns. We can calculate the autocorrelation of Compugen returns to help us make a trade decision. For example, suppose you find that Compugen has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Compugen regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Compugen stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Compugen stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Compugen stock over time.
Current vs Lagged Prices |
Timeline |
Compugen Lagged Returns
When evaluating Compugen's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Compugen stock have on its future price. Compugen autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Compugen autocorrelation shows the relationship between Compugen stock current value and its past values and can show if there is a momentum factor associated with investing in Compugen.
Regressed Prices |
Timeline |
Pair Trading with Compugen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Compugen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compugen will appreciate offsetting losses from the drop in the long position's value.Moving together with Compugen Stock
Moving against Compugen Stock
0.85 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
0.74 | EWTX | Edgewise Therapeutics | PairCorr |
0.7 | EXEL | Exelixis | PairCorr |
0.51 | VRDN | Viridian Therapeutics | PairCorr |
0.41 | FLGC | Flora Growth Corp | PairCorr |
The ability to find closely correlated positions to Compugen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Compugen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Compugen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Compugen to buy it.
The correlation of Compugen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Compugen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Compugen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Compugen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Compugen Correlation, Compugen Volatility and Compugen Alpha and Beta module to complement your research on Compugen. To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Compugen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.